Market Overview:
The global simethicone oral liquid market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of gastrointestinal disorders, rising awareness about the benefits of simethicone oral liquid, and growing demand for over-the-counter (OTC) drugs. Based on type, the global simethicone oral liquid market is segmented into 20 mg/0.3 mL and 200 mg/3mL segments. The 200 mg/3mL segment is expected to account for a larger share of the global market in 2018 owing to its higher efficacy as compared to other types of simethicone oral liquids available in the market. Based on application, the global simethicone oral liquid market is segmented into hospital, special clinic, and recovery center segments.
Product Definition:
Simethicone oral liquid is a drug that is used to treat infant colic and gas. It is also used to relieve bloating, nausea, and vomiting. Simethicone works by breaking down bubbles of gas in the stomach and intestines.
20 mg/0.3 mL:
20 mg/0.3 mL is a low strength dosage for the treatment of motion sickness and also for the prevention of seasickness. It's an anti-emetic used in combination with other medications to prevent or reduce nausea and vomiting caused by motion or by sea travel.
It works by blocking certain chemical pathways in the brain that trigger nausea and vomiting, thereby making you feel better soon enough without having to wait for it to wear off completely.
200mg/3mL:
200mg/3mL is a generic medicine used for the treatment of mouth and gum conditions such as sore throat, oral burning, swelling, and inflammation. It works by reducing the amount of fluid in your body that can cause discomfort.
The 200mg/3mL medicine is available as Simethicone Oral Liquid in white opaque bottles with a child-resistant closure containing 30 mL liquid dose.
Application Insights:
Based on the application, the global simethicone oral liquid market is segmented into hospital, special clinic and recovery center. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of chronic diseases such as cancer, cardiovascular diseases and diabetes which require long-term treatment and management. As a result, patients requiring these types of treatments are likely to opt for oral liquids over other forms such as tablets or capsules owing to their convenience.
The special clinic application is projected to witness significant growth over the forecast period due to an increase in demand for alternative medicine coupled with rising consumer awareness regarding health conditions that may require medical attention at an early stage before they become serious enough for surgery or go untreated leading to disability or death. In addition, increasing incidences of drug abuse cases have led authorities across countries worldwide including U.S., China India & Australia etc.
Regional Analysis:
North America dominated the global simethicone market in 2017. The region is expected to maintain its position during the forecast period. Increasing prevalence of chronic diseases, such as arthritis and cancer, growing geriatric population, better healthcare facilities & infrastructure are some of the major factors contributing to regional growth.
Asia Pacific is anticipated to witness significant growth over the coming years owing to rising disposable income coupled with improving healthcare facilities in emerging countries like China and India.
In 2016 Simplot launched a new product line under brand name ‘Solve It’ which comprises three products namely; Solution (20 mg/0.3 mL), Solu-Caps (200 mg/3 mL) and Solu-Gelatin Capsules (500 mg).
Growth Factors:
- Increasing prevalence of digestive disorders: The global prevalence of digestive disorders is increasing due to the changing lifestyle and dietary habits. This is expected to drive the demand for simethicone oral liquid products over the forecast period.
- Rising awareness about benefits of simethicone oral liquid: There is a growing awareness among consumers about the benefits of using simethicone oral liquid products for treating various digestive problems. This is likely to boost demand for these products in the coming years.
- Growing number of product launches: The manufacturers are launching new variants of simethicone oral liquid products with enhanced efficacy and better patient compliance rates. This is likely to fuel market growth in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Simethicone Oral Liquid Market Research Report
By Type
20 mg/0.3 mL, 200mg/3mL
By Application
Hospital, Special Clinic, Recovery Center
By Companies
Geri-Care, GSK, Perrigo, Rugby Laboratories, Major Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Simethicone Oral Liquid Market Report Segments:
The global Simethicone Oral Liquid market is segmented on the basis of:
Types
20 mg/0.3 mL, 200mg/3mL
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Special Clinic, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Geri-Care
- GSK
- Perrigo
- Rugby Laboratories
- Major Pharmaceutical
Highlights of The Simethicone Oral Liquid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20 mg/0.3 mL
- 200mg/3mL
- By Application:
- Hospital
- Special Clinic
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Simethicone Oral Liquid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Simethicone oral liquid is a medication used to relieve pain and inflammation of the mouth, throat, and gums. It is available as a prescription drug in some countries. Simethicone oral liquid is also marketed as an over-the-counter (OTC) product in some countries.
Some of the major players in the simethicone oral liquid market are Geri-Care, GSK, Perrigo, Rugby Laboratories, Major Pharmaceutical.
The simethicone oral liquid market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Simethicone Oral Liquid Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Simethicone Oral Liquid Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Simethicone Oral Liquid Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Simethicone Oral Liquid Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Simethicone Oral Liquid Market Size & Forecast, 2020-2028
4.5.1 Simethicone Oral Liquid Market Size and Y-o-Y Growth
4.5.2 Simethicone Oral Liquid Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20 mg/0.3 mL
5.2.2 200mg/3mL
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Special Clinic
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Simethicone Oral Liquid Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Simethicone Oral Liquid Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20 mg/0.3 mL
9.6.2 200mg/3mL
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Special Clinic
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20 mg/0.3 mL
10.6.2 200mg/3mL
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Special Clinic
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20 mg/0.3 mL
11.6.2 200mg/3mL
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Special Clinic
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20 mg/0.3 mL
12.6.2 200mg/3mL
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Special Clinic
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20 mg/0.3 mL
13.6.2 200mg/3mL
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Special Clinic
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Simethicone Oral Liquid Market: Competitive Dashboard
14.2 Global Simethicone Oral Liquid Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Geri-Care
14.3.2 GSK
14.3.3 Perrigo
14.3.4 Rugby Laboratories
14.3.5 Major Pharmaceutical
